Skip to content

Purse String Suture Device vs. Endoclip for Immediate Endoscopic Procedure Associated Gastrointestinal Perforation

Purse String Suture Device Versus Endoclip in the Treatment of Immediate Endoscopic Procedure Associated Gastrointestinal Perforation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03053232
Enrollment
100
Registered
2017-02-15
Start date
2017-02-01
Completion date
2018-01-31
Last updated
2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Perforation, Intervention

Brief summary

Nowadays, endoscopic techniques have been applied for diagnosing and treating a variety of gastrointestinal diseases, such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR)technique for removing early gastrointestinal mucosal cancers. Endoscopic procedure associated gastrointestinal perforation is one of the the most severe complications, which is associated with high morality and needs timely detection and effective treatment in clinical practice.Over 90% procedure associated gastrointestinal perforation occurs immediately within 24 h after endoscopic procedure.Endoclips have been widely used in closing the immediate gastrointestinal perforations, but the location of the endoclips could influence the effective rate, limiting its application. In addition, multiple endoclips should be placed under endoscopy for a relatively large perforation, which could increase the medical cost and the procedure time. At recent, a new purse string suture device (LeoMed, China) has been developed by us and introduced to the clinicalmanagement of such patients with procedure associated gastrointestinal perforations. Clinical data validated that the usage of this new purse string suture in treating immediate procedure associated perforations was greatly convenient and effective with very low reoperation rate and postoperative complication rate. A specially designed loop was equipped in this device, which could be tightened under endoscopy. Thus, compared with the placement of endoclips, this device could be more convenient and effective in completely closing the gastrointestinal perforations.This study will test whether purse string suture device will increase the effectiveness of closingimmediate procedure associated gastrointestinal perforationsunder endoscopyin a randomized controlled trialby comparing the use of purse string suture deviceand endoclips.

Detailed description

This is a randomized controlled trial comparing the use of purse string suture device versus endoclips for closing procedure associated gastrointestinal perforation under endoscopy, which is one of the most severe complications and needs timely treatment. Endoclips have been widely used in closing the gastrointestinal perforations, but the location of the endoclips could significantly influence the effective rate. In addition, multiple endoclips will be needed for a relatively large perforation, which could increase the medical cost and the procedure time. At recent, a new purse string suture device has been developed and introduced to the clinicalmanagement of such patients with gastrointestinal perforations. A loop was equipped in this device, which could be tightened. Thus, compared with endoclips, this device could be more convenient and effective in completely closing the gastrointestinal perforations. This study will test whether purse string suture device will increase the effectiveness of treating procedure associated gastrointestinal perforations under endoscopy in a randomized controlled trial.

Interventions

DEVICEPurse string suture device

Using purse string suture device to close gastrointestinal perforation under endoscopy.

DEVICEEndoclips

Using endoclips to close gastrointestinal perforation under endoscopy.

Sponsors

Affiliated Hospital to Academy of Military Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥18 Years * Immediate procedure associated gastrointestinal perforation (i.e. post-ESD perforation, post-EMR perforation;complications of endoscopic examination and procedure) * American Society of Anesthesiology risk class 1, 2 or 3

Exclusion criteria

* Patients \<18 years * Patients with thrombocytopenia (platelet count \< 50,000/microL) or elevated - International Normalized Ratio (INR \> 1.5) * Hemodynamic instability * Pregnancy and lactation * Patients who are unable or unwilling to give an informed consent * Chronic fistula following abdominal surgery * Pyriform fossa perforation

Design outcomes

Primary

MeasureTime frameDescription
Technique success rate1 yearPercentage of patients who successfully receive endoscopical interventions

Secondary

MeasureTime frameDescription
Postoperative complication rate1 yearPercentage of patients who have complications including death after procedure
Reoperation rate1 yearPercentage of patients who need a secondary operation
Operation time1 yearThe time length of the endoscopic operation will be recorded in the unit of minute.
Effective rate1 yearPercentage of patients whose clinical symptoms are alleviated and perforations closed
Postoperative hospitalization1 yearThe length of the hospitalizatioin after operation will be recorded in the unit of day.
Time to resume diet1 yearWhen the patients resume diet will be monitored and recorded.
Medical cost1 yearThe medical cost for the operation and hospitalization will be recorded and collected.
Postoperative pain1 yearPostoperative pain will be evaluated on a visula analogue score (VAS).

Countries

China

Contacts

Primary ContactXiaotian Sun, M.D., Ph.D.
xiaotian-sun@hotmail.com+86-010-66947473
Backup ContactMin Min, M.D., Ph.D.
minmin823@sina.com+86-010-66947473

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026